A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities

Human epidermal growth factor receptor 2 (HER2) is overexpressed in approximately 20% to 30% of breast cancers and various other types of cancers, which plays a vital role in the cancer progression. Monoclonal antibodies targeting Her2 are now used in the clinic to treat Her2 overexpression cancer p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Wu, Xiaoqiong, Chen, Siqi, Lin, Limin, Liu, Jiayu, Wang, Yanlan, Li, Yumei, Li, Qing, Wang, Zhong
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2018
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5852409/
https://ncbi.nlm.nih.gov/pubmed/29455083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.01.024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars